Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice. (2023)
Attributed to:
The role of B cell regulation in type 1 diabetes in NOD mice
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1227133
PubMed Identifier: 37731505
Publication URI: http://europepmc.org/abstract/MED/37731505
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in immunology
ISSN: 1664-3224